PARAMETEREXTRAKTION ZUR BESTIMMUNG DER ANALYTKONZENTRATION

Patent europeic · EP4175545 · En vigur

Inscripziun en il register

Numer da publicaziun: EP4175545
Numer da la dumonda: EP21763243
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 04-08-2021
Publitgà: 10-05-2023
Concedì: 24-06-2026
La protecziun finescha il pli tard: 03-08-2041
Proxima taxa annuala scadenta: 31-08-2026
Classas IPC: A61B 5/145 (2006.01)
A61B 5/1495 (2006.01)
Prioritad: US 202063061135 P 04.08.2020
US 202063061152 P 04.08.2020
US 202063061157 P 04.08.2020
US 202063061167 P 04.08.2020
Dumonda PCT: PCT/EP2021/071743 04.08.2021
Publicaziun PCT: WO2022/029164 10.02.2022
Lingua da l’annunzia: englais
Funtauna: Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

24-06-2026
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 24.06.2026

Partidas

Possessur

Ascensia Diabetes Care Holdings AG

Peter-Merian Strasse 90, 4052 Basel

Inventur

WU, Huan-Ping

Granger, Indiana 46530, US

CERUTTI, Mark D.

Everett, Massachusetts 02149, US

HARRISON, Bern

Mocow, Idaho 83843, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.